Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.010 (0.88%)
At close: Mar 9, 2026, 4:00 PM EDT
1.140
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $25.52 million as of March 9, 2026. Its market cap has decreased by -42.78% in one year.
Market Cap
25.52M
Enterprise Value
-33.36M
1-Year Change
-42.78%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $25.52M, a decrease of -92.83%. That is a compound annual growth rate of -74.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 25.29M | -5.83% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 27.39M |
| Cue Biopharma | 27.35M |
| Passage Bio | 26.95M |
| AEON Biopharma | 26.82M |
| Evaxion | 26.52M |
| Exicure | 26.45M |
| Hyperion DeFi | 26.12M |
| Senti Biosciences | 25.37M |